Cargando…

Cattle encephalon glycoside and ignotin injection improves cognitive impairment in APPswe/PS1dE9 mice used as multitarget anti-Alzheimer’s drug candidates

BACKGROUND: Cattle encephalon glycoside and ignotin injection (CEGI), a multitargeted neurotrophic drug, has been widely used in the treatment of central and peripheral nerve injuries, such as stroke, hypoxic ischemic encephalopathy, and diabetic neuropathy in the People’s Republic of China. However...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Ya, Hu, Ya-zhuo, Li, Rui-sheng, Han, Zhi-tao, Geng, Yan, Xia, Zheng, Du, Wen-jin, Liu, Li-xin, Zhang, Hong-hong, Wang, Lu-ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356454/ https://www.ncbi.nlm.nih.gov/pubmed/25784809 http://dx.doi.org/10.2147/NDT.S78025

Ejemplares similares

Neuroprotection by cattle encephalon glycoside and ignotin beyond the time window of thrombolysis in ischemic stroke
por: Zhong, Jun, et al.
Publicado: (2020)

Cattle encephalon glycoside and ignotin reduced white matter injury and prevented post-hemorrhagic hydrocephalus in a rat model of intracerebral hemorrhage
por: Li, Rongwei, et al.
Publicado: (2016)

Efficacy of cattle encephalon glycoside and ignotin in patients with acute cerebral infarction: a randomized, double-blind, parallel-group, placebo-controlled study
por: Zhang, Hui, et al.
Publicado: (2020)

Effects of Immunocytokine Combined with Cattle Encephalon Glycoside and Ignotin on CTGF, HO-1 and NT-3 in Patients with Type 2 Diabetic Peripheral Neuropathy
por: SUN, Jianguo, et al.
Publicado: (2017)

Mitochondrial dynamics changes with age in an APPsw/PS1dE9 mouse model of Alzheimer’s disease
por: Xu, Lin-Lin, et al.
Publicado: (2017)

Is Strychnia Cumulative in the System?—Does It Affect the Encephalon?
por: Thomas, W. G.
Publicado: (1857)

High fat diet exacerbates Alzheimer's disease-related pathology in APPswe/PS1 mice
por: Thériault, Peter, et al.
Publicado: (2016)

Cardiomyocyte Contractile Dysfunction in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease
por: Turdi, Subat, et al.
Publicado: (2009)

The Protective Effect of Vanadium on Cognitive Impairment and the Neuropathology of Alzheimer’s Disease in APPSwe/PS1dE9 Mice
por: He, Zhijun, et al.
Publicado: (2020)

Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer’s disease-related pathologies in APPswe/PS1dE9 transgenic mice
por: Tsai-Teng, Tzeng, et al.
Publicado: (2016)

Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer’s disease
por: Wu, Wen-Yu, et al.
Publicado: (2017)

YXQN Reduces Alzheimer’s Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice
por: Wang, Xiaowan, et al.
Publicado: (2017)

Paresthesia of right encephalon creativity secondary to residency application anxiety
por: Mohammed, Denelle
Publicado: (2020)

The Normal and Pathological Circulation in the Central Nervous System (Myel-Encephalon)
Publicado: (1897)

Case of Supposed Pigmentary Deposit in the Cortical Substance of the Entire Encephalon
por: Hagenbuch, A. W.
Publicado: (1876)

Mitochondrial biogenesis mediated by melatonin in an APPswe/PS1dE9 transgenic mice model
por: Song, ChaoYuan, et al.
Publicado: (2018)

Motor Cortex Theta and Gamma Architecture in Young Adult APPswePS1dE9 Alzheimer Mice
por: Papazoglou, Anna, et al.
Publicado: (2017)

Whole transcriptome approach to evaluate the effect of aluminium hydroxide in ovine encephalon
por: Varela-Martínez, Endika, et al.
Publicado: (2020)

Comparative anatomy of the encephalon of new world primates with emphasis for the Sapajus sp
por: de Abreu, Tainá, et al.
Publicado: (2021)

Genome-Wide Analysis of miRNA Signature in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease
por: Luo, Hongxue, et al.
Publicado: (2014)

Microvascular ultrastructural changes precede cognitive impairment in the murine APPswe/PS1dE9 model of Alzheimer’s disease
por: Kelly, Patricia, et al.
Publicado: (2017)

Andrographolide promotes hippocampal neurogenesis and spatial memory in the APPswe/PS1ΔE9 mouse model of Alzheimer’s disease
por: Arredondo, Sebastian B., et al.
Publicado: (2021)

Mechanisms Mediating the Protective Effects of Eicosapentaenoic Acid in Brain of the APPswePS1dE9 Alzheimer's Mouse Model
por: Yavari, Mahsa, et al.
Publicado: (2022)

Transcriptome analysis of fasudil treatment in the APPswe/PSEN1dE9 transgenic (APP/PS1) mice model of Alzheimer’s disease
por: Yan, Hailong, et al.
Publicado: (2022)

Amyloid pathology induces dysfunction of systemic neurotransmission in aged APPswe/PS2 mice
por: Oh, Se Jong, et al.
Publicado: (2022)

Gender-Specific Hippocampal Dysrhythmia and Aberrant Hippocampal and Cortical Excitability in the APPswePS1dE9 Model of Alzheimer's Disease
por: Papazoglou, Anna, et al.
Publicado: (2016)

Multitarget therapeutic strategies for Alzheimer’s disease
por: Ibrahim, Mostafa M., et al.
Publicado: (2019)

Selecting Multitarget Peptides for Alzheimer’s Disease
por: Kasus-Jacobi, Anne, et al.
Publicado: (2022)

Amelioration of cognitive impairments in APPswe/PS1dE9 mice is associated with metabolites alteration induced by total salvianolic acid
por: Shen, Li, et al.
Publicado: (2017)

New Multitarget Hybrids Bearing Tacrine and Phenylbenzothiazole Motifs as Potential Drug Candidates for Alzheimer’s Disease
por: Rajeshwari, Rajeshwari, et al.
Publicado: (2019)

Sex-specific hippocampal metabolic signatures at the onset of systemic inflammation with lipopolysaccharide in the APPswe/PS1dE9 mouse model of Alzheimer’s disease
por: Agostini, Alessandra, et al.
Publicado: (2020)

Corrigendum: Amyloid pathology induces dysfunction of systemic neurotransmission in aged APPswe/PS2 mice
por: Oh, Se Jong, et al.
Publicado: (2022)

The Impact of Bdnf Gene Deficiency to the Memory Impairment and Brain Pathology of APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease
por: Rantamäki, Tomi, et al.
Publicado: (2013)

Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 mice
por: Ettcheto, Miren, et al.
Publicado: (2021)

Reactive astrocytes as treatment targets in Alzheimer's disease—Systematic review of studies using the APPswePS1dE9 mouse model
por: Smit, Tamar, et al.
Publicado: (2021)

Memantine Derivatives as Multitarget Agents in Alzheimer’s Disease
por: Marotta, Giambattista, et al.
Publicado: (2020)

Utilization of APPswe/PS1dE9 Transgenic Mice in Research of Alzheimer's Disease: Focus on Gene Therapy and Cell-Based Therapy Applications
por: Malm, Tarja, et al.
Publicado: (2011)

Analysis of differential plaque depositions in the brains of Tg2576 and Tg-APPswe/PS1dE9 transgenic mouse models of Alzheimer disease
por: Kim, Tae-Kyung, et al.
Publicado: (2012)

Tocotrienol Rich Fraction Supplementation Modulate Brain Hippocampal Gene Expression in APPswe/PS1dE9 Alzheimer’s Disease Mouse Model
por: Wan Nasri, Wan Nurzulaikha, et al.
Publicado: (2019)

In Silico Studies on Compounds Derived from Calceolaria: Phenylethanoid Glycosides as Potential Multitarget Inhibitors for the Development of Pesticides
por: Loza-Mejía, Marco A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4sutoo0760k5o27koi7g3lor57